| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $2.9M | -25.7% |
| Cost of Revenue | $1.0M | -65.9% |
| Gross Profit | $1.9M | +105.3% |
| R&D Expense | $2.9M | -53.4% |
| SG&A Expense | $44.7M | -7.2% |
| Operating Income | -$177.0M | +1.9% |
| Interest Expense | $2.9M | -21.8% |
| Income Tax | $32K | +105.5% |
| Net Income | -$140.3M |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $41.0M | -80.0% |
| Accounts Receivable | $762K | -77.1% |
| Inventory | $0 | -100.0% |
| Current Assets | $69.3M | -68.0% |
| Total Assets | $374.9M | -23.0% |
| Current Liabilities | $33.4M | -15.9% |
| Total Liabilities | $94.5M | -14.8% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$162.1M | -7.7% |
| Capital Expenditures | $2.9M | +85.7% |
| Investing Cash Flow | -$14.5M | +90.4% |
| Financing Cash Flow | $18.9M | -94.8% |
| Free Cash Flow | -$165.0M | -8.5% |
| +29.6% |
| EPS (Basic) | $1.07 | -45.1% |
| EPS (Diluted) | $1.07 | -45.1% |
| Stockholders' Equity |
| $268.6M |
| -28.2% |